Outcomes of temporary mechanical circulatory support in cardiogenic shock due to end-stage heart failure.
Hoong Sern LimAaron RanasingheDavid QuinnColin ChueJorge MascaroPublished in: Journal of the Intensive Care Society (2021)
Our temporary MCS strategy, including earlier intervention in patients with CS due to ESHF at INTERMACS 2 was associated with less organ dysfunction and better 90-day survival compared to INTERMACS 1 patients.